In recent years, Chinese pharmaceutical excipients industry has made great progress. There are a number of specialized medical supplements manufacturers. Chinese pharmaceutical excipients market size has been expanded each year and the glutathione market demand for an annual growth rate is about 15% to 20%. Part of the backbone enterprises have developed rapidly. The qualities of products, business services and awareness have been improved significantly.

At present, in the field of global pharmaceutical excipients, Europe and the United States in the forefront, ahead of their level of development about 30 years. Although Chinese companies are basically able to produce the vast majority of species, but the remaining gap in the product technology stability, batch uniformity, and serialization of products and fine so. In recent years, the level of production of Chinese medicinal materials production enterprises increased dramatically shrinking the gap with the developed countries, some manufacturers more and more attention to the new accessories R & D, customer needs that the standard has become the management philosophy of many companies. At present, Chinese enterprises R & D of new pharmaceutical excipients is more difficult, and should therefore focus on meticulous research and the synergy of the existing accessories for the market to provide more specifications and two or more premixed products.

Efforts to improve the performance of pharmaceutical excipients are pharmaceutical excipients manufacturers to track industry trends, and seek an effective way to quickly upgrade. Accessories performance and the mechanism is more complex, accessories quality is good or bad is reflected in its performance indicators. Lobes often appear in the finished products, fragile, degradation, oxidation of a variety of quality issues, the establishment of a multi-purpose, high standards of preparation laboratory, equipped with rich resveratrol preparation technology, engineering and technical personnel, to strengthen the right accessories products than capacity, swelling ratio performance.

Accessories are special products. Manufacturers should be aware of the customers in the production process, and with the right products to remove these drawbacks. Chinese medicinal materials to meet the needs of pharmaceutical companies diversify enough homework. Attention and customer communication, carefully study the individual needs of customers, R & D efforts, production for the products of different preparations, developing and implementing the development strategy of refinement, according to the requirements of the different processes of drug production enterprises, and to adjust the production process and quality system, The swelling degree for the specific volume of the magnesium stearate, sodium carboxymethyl starch, microcrystalline cellulose, mobility and size to work out a lot of internal control indicators.

In fact, in recent years, pharmaceutical excipients industry obtains a rapid development. But it also faces with issues such as disorderly competition. Management system is not perfect, the pharmaceutical manufacturers of pharmaceutical excipients in the bidding, concerned about product pricing, and less attention to product quality, highly competitive market price of pharmaceutical excipients, pharmaceutical excipients manufacturers meager profits, many companies are unable to increase R & D , quality control inputs. Industry due to the low barriers to market in a vicious competition. Enterprises need to integrate resources and change the unfavorable situation through increased supervision, to set up self-regulatory organization.

For the problem of low concentration in Chinese medicinal materials industry, there are many Chinese enterprises in production of materials. Most of them are small and medium-sized pharmaceutical excipients manufacturers. These enterprises are small with poor production conditions, backward technology, obsolete equipment and low level of management. That is not conducive to the healthy development of industry. To change this state, we must continually raise the industry threshold, regulating accessories production management to develop uniform quality standards and promote industrial integration by strengthening supervision manner, supporting the strength of the standardized operation. It will make the pharmaceutical raw materials enterprises bigger and stronger. In addition, manufacturers of pharmaceutical excipients should also be cooperation with universities and research institutions thus forming mutually beneficial win-win industry with research combining Community. In fact, in Europe, America, Japan and other developed countries and regions, the industry association of pharmaceutical excipients plays an important role in industry self-regulation and maintenance of market order.Source:http://www.cospcn.com